SCHEMBL25025809

SCHEMBL25025809

CCCC(C)c1nc(C)n(C)c1C(C)C

nearest known ligand 0.33

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
FPR2 P25090 4/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25027495 0.81
SCHEMBL21668151 0.66
SCHEMBL19876769 0.63 FPR2 (0.42) FPR2
SCHEMBL22427801 0.63
SCHEMBL19876958 0.63 FPR2 (0.42) FPR2
SCHEMBL19876768 0.63 FPR2 (0.42) FPR2
SCHEMBL25027821 0.62
SCHEMBL24416275 0.62
SCHEMBL24081554 0.60
SCHEMBL10148293 0.60 HTT (0.30)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023017263-A1 POTASSIUM CHANNEL MODULATORS AUTIFONY THERAPEUTICS LIMITED (GB) 2023-02-16 WO disclosed